am i a candidate for semaglutide Injections & Consultation Who is a Good Candidate

While this can help with weight loss as patients are shifting to a lower calorie intake, for some people this calorie deficit can also cause fatigue

The MHRA and EMA have not issued warnings regarding thrombotic events as a class effect of GLP-1 receptor agonists

Report any suspected side effects to your healthcare professional and consider using the MHRA Yellow Card Scheme

)

Typically, we find that patients taking FDA-approved GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year

FIGURE 7 Recommendation: NAC is a safe drug and may be used as adjuvant therapy in acute and chronic infections